Sie sind hier: Home



The IPT wishes everyone a successful and happy new year 2017!


Laura Hinz has successfully completed her Dissertation in our department. We wish her all the best for her future career!


We congratulate Antonio Sarikas! He recieved the TUM Award for habilitations 2016.

Quelle: Bund der Freunde / Beatrice Vohler

From left to right: Dr. Klaus Dräger (CEO, BMW), Dr. Antonio Sarikas, Prof. Stefan Engelhardt


Congrats to Deepak Ramanujam on his newest publication on "Viral Vector-Based Targeting of miR-21" in Molecular Therapy! Read more.


We congratulate Ivana Ognenoska on successfully completing her Master's Thesis. We wish her all the best for the future.

Welcome to the TUM Institute of Pharmacology and Toxicology (IPT)!

The IPT is part of the Biederstein Campus at the TUM, located between Munich’s popular district Schwabing and the English Garden. Our fully renovated building hosts a growing undefinedteam of scientists and staff, and provides an ideal research infrastructure with modern lab space and high-end scientific equipment.

As a undefinedresearch institute for translational medicine, we dedicate our work to new therapeutics for cardiovascular diseases, which are still the major cause of death worldwide. Our mission is to identify new drug targets, to analyze their function and to develop novel therapeutic strategies.

This would not be possible without bright minds and scientific exchange. We offer some of the best pharmacology undefinedteaching to students, ranging from lectures and award-winning e-learning tools to lab internships, bachelors, masters or PhD theses. The IPT also coordinates the undefinedMunich Heart Alliance, a joint effort of clinicians and scientists to improve the development of novel cardiac therapies. This outstanding research community has then been appointed by the German Ministry for Education and Research (BMBF) as partner site of the German Center for Cardiovascular Research (undefinedDZHK). In addition, we maintain productive collaborations with industrial partners.